Brian J. Corvese
Independent DirectorMr. Brian J. Corvese has been Founder and President of Vencor Capital since 1999. He has been Non-Employee Director at Mink Therapeutics Inc. since July 2017. Mr. Corvese worked on investments in the US and global equity markets as a Managing Director and Partner at Soros Fund Management. From 1988 to 1996, he was a Partner at Chancellor Capital Management. Mr. Corvese has experience in the financial industry. He was a Partner at INVESCO Private Capital. While at Chancellor, he was a portfolio Manager with responsibility for investments made in basic industries, restructurings and special situations, corporate governance investments, as well as founded and managed his own hedge fund. He served as Equity Analyst at New Street Capital Corporation. From 1981 to 1988, he was with Drexel Burnham Lambert as an Equity Analyst following the chemical and specialty chemical industries and participated in a significant number of merger and acquisition activities. While at Drexel, he was a Member of the top chemical and specialty chemical research team, as ranked by Institutional Investor. He had been an Independent Director of Protagenic Therapeutics, Inc. since July 28, 2017. He serves as a Director of National Telecommunications Company. He has been an Independent Director of Agenus Incorporated since March 8, 2007. Mr. Corvese joined the Agenus Inc. in March 2007. Mr. Corvese earned degrees in finance and political science from The University of Rhode Island and attended New York University Graduate School.
Positions
- Company NameAgenus Inc.Stock CodeAGENPositionIndependent DirectorColleagues
- GHGaro H. ArmenFounder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman
- SJSteven J. O’DayChief Medical Officer
- JSJennifer S. BuellDirector and President & CEO of MiNK Therapeutics
- CWCraig WinterChief Information Officer
- ZAZack ArmenVice President of Investor Relations & Corporate Development
- TJTodd Jude YanceyMember of Advisory Board & Chief Strategic Advisor
- BJBrian J. CorveseIndependent Director
- TLThomas L. HarrisonIndependent Director
- Company NameMiNK Therapeutics, Inc.Stock CodeINKTPositionIndependent DirectorColleagues
- GHGaro H. ArmenExecutive Chairman
- JSJennifer S. BuellCo-Founder, President, CEO & Director
- MOMelissa OrilallPrincipal Financial Officer
- ACAustin CharettePrincipal Accounting Officer
- TCTerese C. HammondHead of Inflammatory & Pulmonary Diseases
- PBPeter BehnerIndependent Director
- BABarbara A. RyanIndependent Director
- Company NameProtagenic Therapeutics, Inc.Stock CodePTIXPositionIndependent Director
